Posts

Showing posts from June, 2023

Vitamin Fortified and Mineral Enriched Food and Beverage Market Value Projected to Expand by 2029

The  global vitamin fortified and mineral enriched food and beverage market  is anticipated to grow at a considerable CAGR of 6.8% during the forecast period. The growing awareness about nutrient deficiency such as vitamin A, D, iron, and other nutrients is boosting the global vitamin fortified and mineral enriched food and beverage market during the forecast period. According to the World Health Organization (WHO), in 2019, around 29.9% of women aged 15-49 years suffered from anaemia. 39.8% of children aged 6-59 months years suffered from anaemia. •              According to WHO, around 250,000–500,000 children who are vitamin A-deficient become blind every year, and half of them die within 12 months of losing their sight. Vitamin A deficiency makes a person blind by making the cornea very dry and then damaging the retina and cornea. •              Acc...

Ceramic Ferrule Market Is Likely to Experience a Tremendous Growth by 2029

Ceramic ferrule market is anticipated to grow at a CAGR of 5.0% during the forecast period. The major factor   behind the growth of the market is the increasing adoption of fiber optics technology across the globe. In addition, the roll out of 5G wireless network across the globe is one of the major factors, which will fuel the growth of the market during the forecast period. The ferrule is one of the most important components in the Fiber optic cable. It is made up of various materials such as plastic, stainless steel, ceramic, and many others. Today, most of the fiber optic cables have ceramic ferrule because of the properties it possesses, which include low insertion loss required during the optical transmission, high strength, small elasticity coefficient, easy control of product characteristics, and it can withstand various environmental changes. Across the globe, many organizations and countries are adopting fiber optic technology, due to increasing preference towards...

Electrical Network Analyser Market to Witness Astonishing Growth by 2029

Electrical network analyser market is estimated to grow at a significant CAGR during the forecast period. As with most other electrical devices, a network analyser requires regular calibration, usually once a year and is accomplished in a calibration laboratory by a manufacturer or a third party. With the change from 3G to LTE technology, the demand for testing equipment throughout communication has increased the demand for network analysers. In addition, the rapid development of 5G technology, driven partially by a rapidly growing demand for new IoT applications where more accurate and lower latency is necessary, is gaining traction. In the automobile sector, several technologies such as artificial intelligence (AI), machine training, IoT, 5G technology and many others are rapidly increasing to promote the development and growth of connected, autonomous vehicles globally. Companies such as BMW, Tesla, Audi and many more already introduced these automobiles although many other corpo...

CAR T cell Therapy Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2029

CAR T cell therapy market is estimated to grow at a CAGR of nearly 48% during the forecast period. The major factors contributing to the growth of the market include a significant prevalence of cancer across the globe and rising FDA approvals for cell and gene therapy. As per the World Health Organization (WHO), the global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018. There were 43.8 million persons living with cancer in 2018 who were diagnosed within the last 5 years. This rising prevalence of cancer is attributing to the development of CAR T cell therapy. It is a form of immunotherapy that utilizes specially altered T cells, a part of the immune system to attack cancer.  There are currently two CAR T cell therapies approved for the treatment of cancer, which includes Yescarta and Kymriah. Yescarta was approved by the US FDA in October 2017, for the treatment of diffuse large B-cell lymphoma (DLBCL). Kymriah was approved by t...